Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Mei Pharma Inc (NQ: MEIP )

2.910 USD +0.040 (+1.39%)
Official Closing Price Updated: 4:56 PM EST, Dec 4, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 346,149
Open 2.870
Bid (Size) 2.780 (1)
Ask (Size) 2.900 (3)
Prev. Close 2.870
Today's Range 2.845 - 2.920
52wk Range 0.7200 - 4.460
Shares Outstanding 70,326,737
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights
--Expands Clinical Development of Zandelisib to New Indications and Earlier Lines of Treatment-- 
From PR Newswire
MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences
MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced its participation in the following upcoming virtual investor... 
From PR Newswire

Performance

YTD
+21.25%
+21.25%
1 Month
+2.83%
+2.83%
3 Month
+18.29%
+18.29%
6 Month
-21.98%
-21.98%
1 Year
+50.00%
+50.00%

More News

Read More
SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Reminds MEI Pharma, Inc. (MEIP) Investors of Class Actionc Suit
Tags banking/finance/investment aviation/aerospace c:united/states
From EIN Presswire
Lifshitz Law Firm, P.C. Announces Investigation of Cognizant Technology Solutions Corporation, Honeywell International Inc., MEI Pharma, Inc., Nikola Corporation, The Chemours Company and YayYo, Inc.
From PR Newswire
SHAREHOLDER ALERT FILING DEADLINE: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – MEIP
From GlobeNewswire News Releases
MEIP FINAL DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important Friday Deadline in Securities Class Action - MEIP
From PR Newswire
Shareholder Alert: Robbins LLP Reminds Investors MEI Pharma, Inc. (MEIP) Accused of Misleading Shareholders
From Business Wire News Releases
Portnoy Law: October 9th Deadline Alert in Lawsuit Filed On Behalf of MEI Pharma, Inc. Investors
From GlobeNewswire News Releases
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action – MEIP
From GlobeNewswire News Releases
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma
From PR Newswire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MEI Pharma, Inc. and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.